SEC Form 4 reporting owner

Kiely John

Kiely John has filed 4 Form 4 transactions reported between May 6, 2026 and August 13, 2026, as Director of Amneal Pharmaceuticals, Inc..

Name as filed: Kiely John

Open-market buys, 24 mo

None

reported

Open-market sales, 24 mo

$882K

1 lines

Companies

with Form 4 filings

Latest transaction

Aug 13, 2026

transaction date

Roles and reported holdings

AMRXAmneal Pharmaceuticals, Inc.
May 6, 2026 – Aug 13, 2026
Director
Held directly200,252 sh as of Aug 13, 2026 · Form 4
24 months: $882K sold

Transaction history

All 4 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

Date	Company	Type	Shares	Price	Value	Owned after	Filing
Aug 13, 2026	AMRXDirector	GiftCode G · direct	10,000	—	—	200,252	Form 4
Aug 13, 2026	AMRXDirector	Open-market saleCode S · direct	50,000	$17.64	$882K@ $17.64	210,252	Form 4
May 7, 2026	AMRXDirector	Option exerciseCode M · direct	34,819	—	—	260,252	Form 4
May 6, 2026	AMRXDirector	Grant or awardCode A · direct	19,824	—	—	19,824	Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.